Control group | Case group | ||||
---|---|---|---|---|---|
n = 121 | Percentage | n = 121 | Percentage | P value | |
Age (years) | |||||
mean (range) | 51.4 (28–89) | 51.6 (27–94) | 0.738* | ||
<40 | 15 | 12.4 | 19 | 15.7 | 0.725† |
40–59 | 87 | 71.9 | 82 | 67.8 | |
>60 | 19 | 15.7 | 20 | 16.5 | |
AJCC stage (pathological) | |||||
I | 24 | 19.8 | 24 | 19.8 | 1.000† |
IIA | 33 | 27.3 | 33 | 27.3 | |
IIB | 18 | 14.9 | 18 | 14.9 | |
IIIA | 20 | 16.5 | 20 | 16.5 | |
IIIB | 2 | 1.7 | 2 | 1.7 | |
IIIC | 24 | 19.8 | 24 | 19.8 | |
Tumor size (mm) | |||||
0–10 | 19 | 15.7 | 19 | 15.7 | 0.911† |
10 − 19 | 19 | 15.7 | 22 | 18.2 | |
20 − 50 | 68 | 56.2 | 63 | 52.1 | |
>50 | 15 | 12.4 | 17 | 14.0 | |
Positive axillary nodes | |||||
None | 47 | 38.8 | 49 | 40.5 | 0.956† |
1–3 | 32 | 26.4 | 32 | 26.4 | |
>4 | 42 | 34.7 | 40 | 33.1 | |
Margin | |||||
Negative | 112 | 92.6 | 106 | 87.6 | 0.197 |
Positive | 9 | 7.4 | 15 | 12.4 | |
Estrogen/progesterone receptor status | |||||
Negative | 46 | 38.0 | 44 | 36.4 | 0.790† |
Positive | 75 | 62.0 | 77 | 63.6 | |
Her2 statusa | |||||
Negative | 92 | 76.0 | 88 | 72.7 | 0.556 |
Positive | 29 | 24.0 | 33 | 27.3 | |
Triple-negative cancer | |||||
Negative | 100 | 82.6 | 95 | 78.5 | 0.417 |
Positive | 21 | 17.4 | 26 | 21.5 | |
MBD quartiles | |||||
1 (0–25%) | 29 | 24.0 | 10 | 8.3 | 0.023† |
2 (25–50%) | 53 | 43.8 | 59 | 48.8 | |
3 (50–75%) | 32 | 26.4 | 41 | 33.9 | |
4 (75–100%) | 7 | 5.8 | 11 | 9.1 | |
Adjuvant chemotherapy | |||||
No | 26 | 21.5 | 21 | 17.4 | 0.417† |
Yes | 95 | 78.5 | 100 | 82.6 | |
Adjuvant hormone therapy | |||||
No | 47 | 38.8 | 50 | 41.3 | 0.694† |
Yes | 74 | 61.2 | 71 | 58.7 | |
Adjuvant target therapy | |||||
No | 100 | 82.6 | 102 | 84.3 | 0.729† |
Yes | 21 | 17.4 | 19 | 15.7 | |
Adjuvant radiotherapy | |||||
No | 59 | 48.8 | 64 | 52.9 | 0.520† |
Yes | 62 | 51.2 | 57 | 47.1 | |
BMI (kg/m2) | |||||
mean (range) | 24.0 (16.2–35.4) | 23.1 (15.4–38.1) | 0.272* | ||
Normal (<25) | 85 | 70.2 | 80 | 64.5 | 0.627† |
Overweight (25–30) | 28 | 23.1 | 33 | 27.3 | |
Obese (>30) | 8 | 6.6 | 10 | 8.3 |